全文获取类型
收费全文 | 21540篇 |
免费 | 2123篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 212篇 |
儿科学 | 720篇 |
妇产科学 | 494篇 |
基础医学 | 2957篇 |
口腔科学 | 409篇 |
临床医学 | 2493篇 |
内科学 | 4448篇 |
皮肤病学 | 306篇 |
神经病学 | 1984篇 |
特种医学 | 725篇 |
外科学 | 2865篇 |
综合类 | 421篇 |
一般理论 | 17篇 |
预防医学 | 2173篇 |
眼科学 | 392篇 |
药学 | 1671篇 |
中国医学 | 23篇 |
肿瘤学 | 1383篇 |
出版年
2021年 | 315篇 |
2020年 | 208篇 |
2019年 | 295篇 |
2018年 | 395篇 |
2017年 | 296篇 |
2016年 | 353篇 |
2015年 | 363篇 |
2014年 | 512篇 |
2013年 | 808篇 |
2012年 | 1106篇 |
2011年 | 1155篇 |
2010年 | 601篇 |
2009年 | 643篇 |
2008年 | 1018篇 |
2007年 | 1135篇 |
2006年 | 1174篇 |
2005年 | 1057篇 |
2004年 | 1067篇 |
2003年 | 935篇 |
2002年 | 952篇 |
2001年 | 576篇 |
2000年 | 569篇 |
1999年 | 514篇 |
1998年 | 258篇 |
1997年 | 248篇 |
1996年 | 220篇 |
1995年 | 216篇 |
1994年 | 211篇 |
1993年 | 183篇 |
1992年 | 363篇 |
1991年 | 390篇 |
1990年 | 409篇 |
1989年 | 353篇 |
1988年 | 323篇 |
1987年 | 293篇 |
1986年 | 298篇 |
1985年 | 286篇 |
1984年 | 253篇 |
1983年 | 228篇 |
1982年 | 194篇 |
1981年 | 153篇 |
1980年 | 162篇 |
1979年 | 206篇 |
1978年 | 182篇 |
1977年 | 163篇 |
1976年 | 169篇 |
1975年 | 125篇 |
1974年 | 160篇 |
1973年 | 135篇 |
1972年 | 158篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
31.
Operative cholangiography 总被引:3,自引:0,他引:3
E H Shively T J Wieman A L Adams R B Romines R N Garrison 《American journal of surgery》1990,159(4):380-4; discussion 385
The value of operative cholangiography in the management of biliary tract disease has been questioned. To better define the role of cholangiography, we reviewed 579 consecutive cholecystectomies done by 1 group of surgeons in a small rural practice over 8 years. Cholangiography demonstrated unsuspected common bile duct disease in 5% of the procedures, while 12% of the patients were spared an unnecessary choledochotomy after a normal cholangiogram was obtained. There was no morbidity, mortality, or prolongation of the hospital stay attributed to the cholangiographic procedure. These findings bolster the argument for routine cholangiography as a safe, effective, and helpful screening examination for patients who are at risk for having common bile duct disease. 相似文献
32.
The flow cytometric crossmatch and early renal transplant loss 总被引:3,自引:0,他引:3
R J Mahoney K A Ault S R Given R J Adams A C Breggia P A Paris G E Palomaki S A Hitchcox B W White J Himmelfarb 《Transplantation》1990,49(3):527-535
Data from this retrospective study indicate that a positive two-color T and/or B cell flow cytometric crossmatch (FCXM) is predictive of early renal allograft loss (less than 2 months) in cadaveric kidney donor recipients who had a negative crossmatch by the antihuman globulin complement-dependent cytotoxicity technique. Among 90 cadaveric kidney donor recipients (67 primary, 23 regrafts), 14 (8 primary, 6 regrafts) lost their renal allografts within 2 months, and 10 of the 14 were FCXM positive and HLA sensitized. The remaining 76 allografts survived beyond 2 months, 12 of which were FCXM-positive. Thus, the FCXM sensitivity rate for detecting early graft loss was 71%, and the specificity rate was 84%. Cadaveric graft-loss rates at 2 months were 33% for primary and 60% for FCXM-positive regrafts in contrast to 7% for primary and 0% for FCXM-negative regrafts. The difference in early graft loss between FCXM-positive and FCXM-negative recipients was statistically significant (P less than 0.0001). Subset analyses of FCXM-positive graft recipients indicate: (1) previous early graft loss contraindicates transplantation of an FXCM-positive regraft (P = 0.03); and (2) panel reactive antibody (PRA) less than or equal to 10% at crossmatch is not associated with early graft loss (P = 0.04). There was no significant difference in 1-year graft survival between primary and regrafts in either FCXM-negative recipients (85% vs. 77%, respectively) or FCXM-positive recipients (67% vs. 40%). All 12 of the FCXM-positive primary and regrafts that survived 2 months continued to function at 2 years. Stepwise logistic regression analysis of 5 independent predictor variables (FCXM status, gender, primary vs. regraft status, PRA level, and HLA mismatched antigens) indicated that the FCXM test was the best predictor of early graft loss. When FCXM results of the 90 cadaveric graft recipients were ranked in three groups, an FCXM channel shift of 29 or greater (third tertile) on a 1024 channel log scale was associated with a 7.0-fold (95% confidence interval 1.9-25.5) increased risk of early graft failure when compared to the first two tertiles. These data indicate that the FCXM offers an additional approach for identifying sensitized patients at risk of early renal allograft loss. 相似文献
33.
The cardiac effects of terfenadine after inhibition of its metabolism by grapefruit juice 总被引:2,自引:0,他引:2
C. P. Clifford D. A. Adams S. Murray G. W. Taylor M. R. Wilkins A. R. Boobis D. S. Davies 《European journal of clinical pharmacology》1997,52(4):311-315
Objective: To determine whether the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine are affected by the concomitant
administration of grapefruit juice.
Methods: Six healthy volunteers were recruited for a balanced cross-over study. Each volunteer received 120 mg terfenadine 30 min
after drinking 300 ml of either water or freshly squeezed grapefruit juice. The alternative treatment was administered on
the second study day 2 weeks later. Measurements of the area under the terfenadine plasma concentration-time curve (AUC),
maximum terfenadine concentration (Cmax) and the time to maximum concentration (tmax) were made, and the corrected QT (QTc) interval was measured from the surface electrocardiogram.
Results: Terfenadine was quantifiable in plasma in all 6 subjects on both study days for up to 24 h post-dosing. The AUC of terfenadine
was significantly increased by concomitant grapefruit administration (median values 40.6 vs 16.3 ng · ml−1 · h), as was the Cmax (median values 7.2 vs 2.1 ng · ml−1). The tmax was not significantly increased and there was no significant change in the median QTc interval despite the increased terfenadine
levels. The 95% confidence interval for the difference in the change in QTc interval at Cmax was −13 to +38 ms.
Conclusion: Administration of grapefruit juice concomitantly with terfenadine may lead to an increase in terfenadine bioavailability,
but the increase observed in this study did not lead to significant cardiotoxicity in normal subjects. However, this does
not exclude the risk of cardiotoxicity in high-risk subjects given greater doses of grapefruit juice over longer periods of
time.
Received: 14 October 1996 / Accepted in revised form: 10 December 1996 相似文献
34.
35.
36.
37.
38.
The definition and diagnosis of asthma 总被引:2,自引:0,他引:2
39.
Cyclosporine A inhibition of microcystin toxins 总被引:2,自引:0,他引:2
Cyclosporine A (CyA) given i.v. at a dose of 1.25 mg/mouse blocks a subsequent i.v. lethal dose (1.7-1.8 x LD50) of microcystin-LR for 24 hr, and is about 50% protective at 48 hr. Conversely, the fraction of mice that can be rescued by CyA (0.2 mg/mouse) after a lethal dose of microcystin-LR decreases rapidly with a pharmacodynamic half-time of only about 100 sec. The prophylactic action of CyA was tested against lethal doses of four microcystins. The acute lethality of 1.7-1.8 x LD50 dose of microcystin-LR, -RR, -LY, or -LA given 1 hr after administration of 0.2 mg of CyA is 0%, 0%, 58%, or 100%, respectively. Even a 0.6 mg/mouse dose of CyA is ineffective prophylaxis against a lethal dose of microcystin-LA. The inhibitory potency of CyA on microcystin toxicity can be completely reversed by the single L-amino acid substitution of alanine for arginine in the microcystin. 相似文献
40.